ECS Dysregulation In Autism Spectrum Disorders: Correlation between Inflammation & Neuro-Immune Alterations

Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations Abstract Several studies highlight a key involvement of endocannabinoid (EC) system in autism pathophysiology. The EC system is a complex network of lipid signaling pathways comprised of arachidonic acid-derived compounds (anandamide, AEA) and 2-arachidonoyl glycerol (2-AG), their G-protein-coupled receptors…

GrowLife, Inc. Announces Strategic Asset Acquisition

GrowLife, Inc. Announces Strategic Asset Acquisition Including Innovative Proprietary Technologies for the Indoor Cultivation Industry David Reichwein to Join GrowLife, Inc. as Vice President of Research and Development October 11, 2017 09:00 AM Eastern Daylight Time KIRKLAND, Wash.–(BUSINESS WIRE)–GrowLife, Inc. (PHOT) one of the nation’s most recognized indoor cultivation services providers, today announced that it has…

Canadian AIDS Society announces Innovative Cannabis Research Program Funded by Canopy Growth Corporation

OTTAWA, July 6, 2017 /CNW/ – The Canadian AIDS Society announced today a first of its kind research program funded by Canopy Growth Corporation. The program is designed to provide up-to-date information on the current state of evidence and research pertaining to the use of cannabis for medical purposes and to build tools for healthcare professionals…

A No-Grow Situation – Medical Marijuana and no growing?

A No-Grow Situation – InMed’s Proprietary Biosynthesis Technology in Cannabinoid Manufacturing   Medical Marijuana … and no growing??? InMed Pharmaceuticals, a pre-clinical stage biopharmaceutical company, is inviting you to take a look at their propriety biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids, all without growing any plants. Recently the company was featured in a…